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Preservation of aerobic fitness and skeletal muscle strength through exercise training can ameliorate meta-
bolic dysfunction and prevent chronic disease. These benefits are mediated in part by extensive metabolic
and molecular remodeling of skeletal muscle by exercise. Aerobic and resistance exercise represent
extremes on the exercise continuum and elicit markedly different training responses that are mediated by
a complex interplay between a myriad of signaling pathways coupled to downstream regulators of transcrip-
tion and translation. Here, we review the metabolic responses and molecular mechanisms that underpin the
adaptatation of skeletal muscle to acute exercise and exercise training.Introduction
Physical inactivity is a known, but modifiable, risk factor that
contributes to lifestyle-related diseases, including many causes
of ‘‘preventable death’’ (Booth et al., 2012). Worldwide, approx-
imately one in three adults and four in five adolescents do not
achieve the recommended quantity and quality of daily exer-
cise (Hallal et al., 2012). Current public health recommenda-
tions recognize regular exercise and physical activity as
a cornerstone in the prevention, management, and treatment
of numerous chronic conditions, including hypertension, coro-
nary heart disease, obesity, type 2 diabetes mellitus (T2DM),
and age-related muscle wasting (sarcopenia) (Haskell et al.,
2007; Colberg et al., 2010). This acknowledgment predicates
the axiomatic understanding that ‘‘exercise is medicine.’’ For
instance, short-term exercise training partially reverses the
progression of metabolic disease (O’Gorman et al., 2006),
whereas lifestyle interventions incorporating increased physical
activity remain the primary preventive approach for metabolic
disease (Knowler et al., 2002). In fact, regular exercise
combined with dietary intervention is more successful than
pharmacological intervention in the treatment and prevention
of T2DM (Knowler et al., 2002) and sarcopenia (Borst, 2004).
While the benefits of and adaptations to regular exercise are
long known, molecular biologists have recently uncovered
networks of signaling pathways and regulatory molecules that
coordinate adaptive responses to exercise. The purpose of
this review is to describe the metabolic and molecular
responses to a single (acute) bout of exercise and chronic
exercise training, while contrasting the adaptive response to
aerobic and resistance exercise. Key mechanistic studies that
utilize transgenic mice and in vitro models of plasticity are
also considered. Due to space limitations, this review focuses
primarily on skeletal muscle, given its hierarchical role in loco-
motion, exercise performance, and metabolic responses, as162 Cell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc.well as the pivotal function in the regulation of metabolic
homeostasis.
The Molecular Basis of Skeletal Muscle Adaptation to
Exercise
Repeated, episodic bouts of muscle contraction, associated
with frequent exercise training, are potent stimuli for physio-
logical adaptation. Over time, skeletal muscle demonstrates
remarkable malleability in functional adaptation and remodel-
ing in response to contractile activity (Flu¨ck and Hoppeler,
2003; Coffey and Hawley, 2007). Training-induced adaptations
are reflected by changes in contractile protein and function
(Adams et al., 1993; Widrick et al., 2002), mitochondrial function
(Spina et al., 1996), metabolic regulation (Green et al., 1992),
intracellular signaling (Benziane et al., 2008), and transcriptional
responses (Pilegaard et al., 2003). The widely accepted
molecular mechanisms that govern the adaptation to exercise
training involve a gradual alteration in protein content and
enzyme activities. These progressive changes reflect activa-
tion and/or repression of specific signaling pathways that
regulate transcription and translation, and exercise-responsive
gene expression (Figure 1). Transient postexercise changes in
gene transcription include immediate early genes, myogenic
regulators, genes of carbohydrate (CHO) metabolism, lipid
mobilization, transport and oxidation, mitochondrial metabolism
and oxidative phosphorylation, and transcriptional regulators
of gene expression and mitochondrial biogenesis (Pilegaard
et al., 2003; Mahoney et al., 2005; Coffey et al., 2006a; Louis
et al., 2007). On a regulatory level, a single bout of exercise
alters the DNA binding activity of a variety of transcription
factors, including MEF2 (Yu et al., 2001), HDACs (McGee
et al., 2009), and NRFs (Baar et al., 2002; Wright et al., 2007).
Protein stability and subcellular localization of transcriptional
factor complexes within the nucleus and mitochondrion are
Figure 1. The Molecular Basis of Adaptation to Exercise
Schematic representation of changes in mRNA expression (bottom panel)
and protein content (middle panel) over time as a consequence of acute
exercise and chronic (repetitive) exercise training. Although each individual
bout of exercise is necessary as a stimulus for adaptation, it alone is insuffi-
cient to alter the muscle phenotype—training-induced phenotypic adaptation
is the consequence of repetition of the stimulus of individual exercise bouts. In
order for a gene upregulated by exercise and training, an individual exercise
bout elicits a rapid, but transient, increase in relative mRNA expression of
a given gene during recovery. Alterations in mRNA expression several-fold
from basal levels are typically greatest at 3–12 hr after cessation of exercise
and generally return to basal levels within 24 hr. The temporal pattern is
specific to a given gene and the exercise challenge. Translational processing
and an elevated rate of postexercise protein synthesis result in a modest,
same-directional change in protein content. Superimposition of repeated
exercise bouts results in the gradual accumulation of protein in response to
repeated, pulsed increases in relative mRNA expression. Thus, long-term
adaptation to training is due to the cumulative effects of each acute exercise
bout leading to a new functional threshold. Training-induced changes in
protein content or enzyme function alter metabolic responses to exercise
at the level of substrate metabolism, resulting in improved exercise perfor-
mance (upper panel). As protein half-lives are usually much longer than
those of mRNA, changes in protein content are more readily observed than
changes in transcript expression in response to training as opposed to acute
exercise.
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Safdar et al., 2011b). Moreover, we have recently shown that
transient DNA hypomethylation of gene-specific promoter
regions precedes increases in mRNA expression in response
to acute exercise (Barre`s et al., 2012). In turn, these pulses of
elevated mRNA during recovery from acute exercise facilitate
the synthesis of respective proteins, and provoke gradual
structural remodeling and long-term functional adjustments
(Perry et al., 2010). In general, these adaptations are intrinsic
to the working skeletal muscle, and collectively contribute
toward maximizing substrate delivery, mitochondrial respiratory
capacity, and contractile function during exercise. The net effect
is to promote optimal performance during a future exercise
challenge, resulting in a robust defense of homeostasis in the
face of metabolic perturbation, and consequently, enhanced
resistance to fatigue (Holloszy and Coyle, 1984; Booth and
Thomason, 1991).Skeletal Muscle Biology and Metabolism
Skeletal muscle comprises 40% of total body mass in
mammals and accounts for 30% of the resting metabolic rate
in adult humans (Zurlo et al., 1990). Skeletal muscle has a critical
role in glycemic control and metabolic homeostasis and is
the predominant (80%) site of glucose disposal under insulin-
stimulated conditions (DeFronzo et al., 1981). Additionally,
skeletal muscle is the largest glycogen storage organ, with/
having 4-fold the capacity of the liver. Remarkably, a single
bout of acute exercise improves whole-body insulin sensitivity
for up to 48 hr after exercise cessation (Mikines et al., 1988;
Koopman et al., 2005). Furthermore, exercise increases skeletal
muscle glucose uptake through an insulin-independent pathway
(Lee et al., 1995), indicating that muscle contraction directly
impacts glucose homeostasis.
Mammalian skeletal muscles are comprised of several fiber
types, of which the major classifications and biochemical
properties have been reviewed in greater detail elsewhere
(Schiaffino and Reggiani, 2011). Skeletal muscle fibers are
defined as slow- or fast-twitch based on the contractile property
of ‘‘time-to-peak tension’’ or ‘‘twitch’’ characteristics (Table 1).
This classification coincides with histochemical staining for
myofibrillar (myosin) ATPase as type I (slow-twitch) and type II
(fast-twitch, highest ATPase activity). A subclassification of
type IIa and type IIx exists in humans, while type IIb is primarily
found in rodents. Type I muscle fibers are classically red in
appearance, type IIx and IIb fibers are white in appearance,
and type IIa fibers have an intermediate color. This difference
in color reflects the abundance of the oxygen transport protein
myoglobin, which is closely related to mitochondrial density
and the relative contribution of oxidative metabolism in the
respective fiber types (each highest in type I fibers). Immunohis-
tochemical staining and electrophoretic protein separation can
independently determine myosin heavy chain (MHC) isoform
protein expression, another key criterion of fiber type classifica-
tion. Each isoform displays distinct contractile properties that
parallel ATPase activity and twitch characteristics. Uniform
fibers containing MHC1, 2A, and 2X exist, while hybrid fibers
containing 1-2A and 2A-2X isoforms have also been reported.
Muscle fiber type is genetically determined during development,
but the adaptive ‘‘transformation’’ of muscle fibers from one type
to another is still hotly debated (Booth et al., 2010). Given an
appropriate training stimulus, the plasticity of muscle permits
changes in metabolic potential and morphology irrespective of
whether a transformation of muscle fiber type measured by
change in MHC expression is observed (Phillips et al., 1996;
Leblanc et al., 2004).
One striking physiological characteristic of skeletal muscle
is a capacity to rapidly modulate rate of energy production,
blood flow, and substrate utilization in response to locomotion.
Locomotion is powered by actin-myosin crossbridge cycling
according to the sliding filament theory of skeletal muscle
contraction (Podolsky and Schoenberg, 1983). Hydrolysis of
adenosine triphosphate (ATP) by myosin ATPase provides the
immediate energy source for crossbridge cycling but is also
consumed to a large extent by dynamics of sodium-potassium
and calcium exchange necessary for contraction. Skeletal
muscle is the principal contributor to exercise-induced changes
in metabolism. Maximal exercise can induce a 20-fold increaseCell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc. 163
Table 1. Contractile, Metabolic, and Morphological Characteristics of Human Skeletal Muscle Fiber Types
Type I
Type II
Type IIa Type IIx
General Properties
Alternative nomenclature SO, ST FOG, FTa FG, FTb
Myosin heavy-chain isoform MHC1 MHC2A MHC2X
Contractile and metabolic characteristics Slow twitch, high oxidative,
fatigue resistant
Fast twitch, oxidative-glycolytic,
fatigue resistant
Fast twitch, glycolytic,
fast fatigable
Force production (power output) Weak Intermediate Strong
Endurance capacity High Intermediate Low
Appearance/myoglobin content Red/high Red/intermediate White/low
Time to peak tension a 80 30
Ca2+ actomyosin ATPase activity b 0.16 0.48
Mg2+ actomyosin ATPase activity c 0.30 0.84
Recruitment threshold All intensities >40%VO2max >75%VO2max
Morphological Properties
Capillary density (capillaries per fiber) 4.2 4.0 3.2
Mitochondrial density High Intermediate Low
Fiber size (cross-sectional area) d 5310 6110 5600
Percent distribution in whole muscle 54.0 ± 12.2 (50–55) 32.3 ± 9.1 (30–35) 13.0 ± 7.6 (10–20)
Myonuclear domain size Small Intermediate Large
Glycolytic and Oxidative Enzyme Activitiese
Creatine kinase 13.1 16.6
Phosphofructokinase 7.5 13.7 17.5
Glycogen phosphorylase 2.8 5.8 8.8
Lactate dehydrogenase 94 179 211
Citrate synthase 10.8 8.6 6.5
Succinate dehydrogenase 7.1 4.8 2.5
3-hydroxyl-CoA dehydrogenase 14.8 11.6 7.1
Metabolic and Substrate Properties
Oxidative potential High Intermediate-high Low
Glycolytic potential Low Intermediate-high High
[Phosphocreatine] f 12.6 14.5 14.8
[Glycogen] f 77.8 83.1 89.2
[IMTG] f 7.1 4.2
Exercise-type dominance Prolonged low intensity Moderate duration, high intensity Short duration, maximal effort
Adapted fromSaltin andGollnick (1983). Relationship between skeletal muscle fiber type and the indicated properties. Data are fromm. vastus lateralis
from untrained men.
amsec.
bmmol min1 mg myosin1.
cmmol min1 g protein1.
dmm2.
emmol kg1 min1 except creatine kinase in mmol min1 g1.
fmmol kg1 wet weight.
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ATP turnover rate within the working skeletal muscle can be
more than 100-fold greater than at rest (Gaitanos et al., 1993).
Although resting intramuscular stores of ATP are small (due to
the four negative charges and hydrophilic nature of free ATP),
activation of metabolic pathways that drive ATP generation
maintains intracellular levels (Figure 2). Skeletal muscle is
richly endowed with mitochondria and heavily reliant on
oxidative phosphorylation for energy production. During stren-164 Cell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc.uous exercise, dramatic (>30-fold) increases in intramuscular
oxygen consumption and local blood flow occur (Andersen
and Saltin, 1985; Gibala et al., 1998). Estimated TCA cycle
flux increases by 70- to 100-fold under the same conditions
(Gibala et al., 1998). Thus, skeletal muscle is the primary site
for CHO and lipid metabolism for energy production. Impor-
tantly, the biochemical consequences of contractile bioener-
getics can regulate molecular processes governing skeletal
muscle adaptation.
Figure 2. Energy Provision in Skeletal Muscle during Exercise
ATP hydrolysis, catalyzed by myosin ATPase, powers skeletal muscle contraction. Metabolic pathways of ATP generation in skeletal muscle include (1) the ATP-
phosphagen system wherein the degradation of PCr by creatine kinase (CK) produces free Cr and Pi, which is transferred to ADP to re-form ATP; the adenylate
kinase (AK) (myokinase) reaction catalyzes the formation of ATP and AMP from two ADPmolecules; (2) anaerobic glycolysis, where glucose-6-phosphate derived
from muscle glycogen (GLY) (catalyzed by glycogen phosphorylase, PHOS) or circulating blood glucose (GLU) (catalyzed by hexokinase, HK), is catabolized to
pyruvate (PYR), which is reduced to lactate (LAC) by lactate dehydrogenase (LDH), and produces ATP by substrate level phosphorylation; (3) processes of
carbohydrate (glycolysis) and lipid (b-oxidation) metabolism producing acetyl-CoA (Ac-CoA), which enters the tricarboxylic acid (TCA) cycle in the mitochondria,
coupled to oxidative phosphorylation in the electron transport chain (ETC). The two main metabolic pathways, i.e., glycolysis and oxidative phosphorylation, are
linked by the enzyme complex pyruvate dehydrogenase (PDH). GLUT4 facilitates glucose uptake to the sarcoplasm, whichmay undergo glycolysis or during rest/
inactivity, be stored as glycogen via glycogen synthase (GS). Fatty acyl translocase (FAT/CD36) facilitates long-chain fatty acid transport at the sarcolemma, and,
in concert with fatty acid binding protein (FABPpm) and carnitine palmitoyltransferase 1 (CPT1), across the mitochondrial membrane. FFAs entering the cell may
be oxidized via b-oxidation or be diverted for storage as IMTG via esterification by monoacylglycerol acyltransferase (MGAT) and diacylglycerol acyltransferase
(DGAT). Liberation of FFAs from IMTG stores via lipolysis in skeletal muscle during exercise occurs via the activities of HSL and ATGL. All pathways of ATP
generation are active during exercise, but the relative contribution of each is determined by the intensity and duration of contraction, as a function of the relative
power (rate of ATP production) and capacity (potential amount of ATP produced). CS, citrate synthase; Cyt c, cytochrome c; PFK, phosphofructokinase.
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Exercise is represented by a potential disruption to homeostasis
by muscle activity that is either exclusively or in combina-
tion concentric, isometric, or eccentric. The use of the term‘‘exercise’’ in scientific research often encompasses several
modifiable variables. These include the modality (e.g., aerobic
versus resistance) and the frequency, intensity, and duration
of exercise sessions—each of which are mitigating factorsCell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc. 165
Table 2. Adaptations andHealthBenefits of Aerobic Compared to
Resistance Exercise
Aerobic
(Endurance)
Resistance
(Strength)
Skeletal Muscle Morphology and Exercise Performance
Muscle hypertrophy 4 [ [ [
Muscle strength and power 4 Y [ [ [
Muscle fiber size 4 [ [ [ [
Neural adaptations 4 [ [ [ [
Anaerobic capacity [ [ [
Myofibrillar protein synthesis 4 [ [ [ [
Mitochondrial protein
synthesis
[ [ 4 [
Lactate tolerance [ [ 4 [
Capillarisation [ [ 4
Mitochondrial density
and oxidative function
[ [ [ 4 [
Endurance capacity [ [ [ 4 [
Whole-Body and Metabolic Health
Bone mineral density [ [ [ [
Body composition
Percent body fat Y Y Y
Lean body mass 4 [ [
Glucose metabolism
Resting insulin levels Y Y
Insulin response to glucose
challenge
Y Y Y Y
Insulin sensitivity [ [ [ [
Inflammatory markers Y Y Y
Resting heart rate Y Y 4
Stroke volume, resting
and maximal
[ [ 4
Blood pressure at rest
Systolic 4 Y 4
Diastolic 4 Y 4 Y
Cardiovascular risk profile Y Y Y Y
Basal metabolic rate [ [ [
Flexibility [ [
Posture 4 [
Ability in activities of daily living 4 [ [ [
Aerobic exercise training generally encompasses exercise durations of
several minutes up to several hours at various exercise intensities, incor-
porating repetitive, low-resistance exercise such as cycling, running, and
swimming. Resistance training generally encompasses short-duration
activity at high or maximal exercise intensities, and increases the
capacity to perform high-intensity, high-resistance exercise of a single
or relatively few repetitions such as Olympic weightlifting, bodybuilding,
and throwing events. [, values increase; Y, values decrease;4, values
remain unchanged;[ orY, small effect;[[ or Y[, medium effect; [[[ or
YYY, large effect;4[ or4Y, no change or slight change.
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endurance-based) and resistance (or strength-based) activities
represent two extremes of the exercise continuum (Table 2).
Aerobic exercise imposes a high-frequency (repetition), low-166 Cell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc.power output (load) demand on muscular contraction, whereas
resistance exercise imposes a low-frequency, high-resistance
demand. Consequently, the metabolic and molecular responses
to the different modalities are distinct, and the specificity of
a given molecular response is coupled to a functional outcome.
This is illustrated by divergent molecular signatures in response
to aerobic versus resistance exercise (Coffey et al., 2006a,
2006b), or similar conditions simulated in vitro (Nader and
Esser, 2001; Atherton et al., 2005), which is consistent with
the divergent physiological and functional adaptations to the
respective exercise modalities, e.g., endurance versus hyper-
trophy phenotype (Booth and Thomason, 1991). Although both
aerobic exercise and resistance training can individually pro-
mote substantial health benefits (Table 2), divergent effects are
observed depending on the parameter of interest. For example,
aerobic training more effectively modifies cardiovascular risk
factors, whereas resistance training more effectively maintains
basal metabolic rate, muscle mass, and physical function in
the elderly. However, compared to either modality alone, a
combination of aerobic and resistance training is more effective
for reducing the insulin resistance and functional limitations in
obesity and the metabolic syndrome (Davidson et al., 2009),
and improving glycemic control in T2DM (Sigal et al., 2007).
The efficacy of combined aerobic and resistance exercise as
part of lifestyle intervention is reflected in the recent exercise
guidelines (Colberg et al., 2010).
The Metabolic Response to an Acute Bout of Exercise
Substrate Utilization during Exercise
During acute exercise, the contribution of various metabolic
pathways to energy provision is determined by the relative inten-
sity and absolute power output of the exercise bout (Figure 3).
The absolute power output determines the rate of ATP demand
and energy expenditure, whereas the relative exercise intensity
influences the relative contributions of CHO and lipid sources,
and circulating (extramuscular) and intramuscular fuel stores,
to energy provision. The use of indirect calorimetry combined
with isotope tracer methodology permitted the assessment of
substrate utilization during exercise (Romijn et al., 1993; van
Loon et al., 2001). The partitioning of fuel sources utilized from
extra- or intramuscular substrates is coordinated quantitatively
and temporally to meet the metabolic demands of exercise.
At low-to-moderate intensities of exercise, the primary fuel
sources supplying skeletal muscle are glucose, derived from
hepatic glycogenolysis (or gluconeogenesis) or oral ingestion,
and free fatty acids (FFAs) liberated by adipose tissue lipolysis.
The contributions of liver and adipose tissue to substrate provi-
sion to contracting muscle during exercise are described in
detail elsewhere (Kjaer, 2006; Horowitz, 2006) and are largely
under the influence of hormonal responses to the onset of exer-
cise (e.g., adrenaline, noradrenalin, glucagon, insulin, cortisol)
(Galbo, 1983). With respect to extramuscular fuel sources,
as exercise intensity increases, muscle utilization of circulating
FFAs declines modestly, whereas utilization of circulating
glucose increases progressively up to near-maximal intensities
(van Loon et al., 2001). This coincides with increasing absolute
rates of CHO oxidation and relative contribution to energy provi-
sion (Figure 3A), with a majority of energy at high intensities of
exercise being provided by muscle glycogen. When exercise at
Figure 3. The Effect of Exercise Intensity and Exercise Duration on
Substrate Metabolism and Muscle Recruitment during Acute
Exercise
The respiratory exchange ratio (RER) is a ratio of CO2 production (VCO2) to O2
consumption (VO2). A value of 0.707 indicates 100% contribution from lipid
sources, whereas a value of 1.0 or greater indicates 100% contribution from
CHO sources. (A) and (B) are representative of the metabolic responses to
exercise in fasted, physically active humans.
(A) Substrate contribution to exercise of increasing intensity. Up to 30%
VO2max, oxidation of lipid sources (mostly plasma FFAs) accounts for the
majority of energy provision. As exercise intensity increases, absolute CHO
oxidation rate and relative contribution to energy provision increases. The lipid
oxidation rate increases up to 60%–70% VO2max, after which it declines as
intensity increases. In relative terms, the contribution of lipid oxidation to
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energy contribution is derived from lipid oxidation. Conse-
quently, the proportion of energy derived from muscle glycogen
declines and is replaced by a progressive increase in plasma
FFA oxidation (Romijn et al., 1993).
Muscle glycogen is the predominant CHO source during
moderate to intense exercise, and the rate of degradation (glyco-
genolysis) is proportional to the relative exercise intensity.
Increased glycogenolysis during exercise occurs via activa-
tion of glycogen phosphorylase, which reflects alterations in
[calcium]i, [inorganic phosphate (Pi)], cAMP-dependent b-adren-
ergic stimulation, and allosteric modulation by AMP and IMP
(Hargreaves, 2006). Higher rates of glycogenolysis occur when
initial muscle glycogen concentrations are high, but as exercise
proceeds, degradation rates parallel declining glycogen levels
and associated glycogen phosphorylase activity. Conversely,
intramuscular triglycerides (IMTGs) constitute only a fraction
(1%–2%) of whole-body lipid stores but are the subject of
intense research in exercise metabolism and metabolic disease
(Kiens, 2006). IMTGs are an important fuel source during pro-
longed (>90 min), moderate intensity exercise and provide
25% of total energy, but tend to contribute less at either higher
or lower intensities of exercise (Romijn et al., 1993; van Loon
et al., 2001). Following exercise, IMTG stores are reduced by
60%, predominantly in type I muscle fibers (van Loon et al.,
2003; Stellingwerff et al., 2007). IMTG breakdown occurs
primarily via hormone-sensitive lipase (HSL) and adipose triglyc-
eride lipase (ATGL) (Watt and Spriet, 2010), although the regu-
lation of exercise-mediated lipase activity is incompletely
described. As with aerobic exercise, both muscle glycogen
and IMTG contribute to energy provision during resistance
exercise (Koopman et al., 2006). However, questions remain
regarding regulatory control of CHO and lipid utilization during
exercise. In summary, skeletal muscle substrate utilization
during exercise is influenced by (1) intrinsic exercise-related
factors including intensity, duration, and mode of exercise; (2)
metabolic factors including muscle recruitment patterns, enzy-
matic capacities, rates of substrate delivery, energy charge
status, and activity of substrate cycles; and (3) external factors
including environmental conditions, nutritional status, age, andenergy provision decreases proportionally with increasing exercise intensity,
as reflected by a steady rise in RER.
(B) Substrate contribution to exercise at a fixed intensity (e.g., 65%VO2max) for
an extended duration. An initial rise in RER occurs at the onset of exercise,
reflecting the increase in relative contribution of CHO to energy provision
compared to restingmetabolism. Thereafter, a small but steady decline in RER
is observed with extended duration of exercise, reflecting the declining relative
contribution of CHO to energy provision as a function of the increasing relative
contribution of lipid.
(C) Recruitment of muscle fibers is dependent on the intensity and duration of
contraction. A hierarchal recruitment pattern of type I to IIa to IIx/b occurs as
force output of the muscle increases from low to high. During low-intensity
exercise, slow-twitch, type I fibers are recruited, which have a high capacity for
fat oxidation and a low capacity for glycogenolysis-glycolysis. An increase in
contraction intensity results in a proportional increase in the recruitment of
type II muscle fibers, which by their intrinsic characteristics generatemore ATP
from glycolytic pathways. Themetabolic advantage is that these CHO-derived
pathways produce ATP at a higher power (mol ATP s1) and at a lower rate of
oxygen consumption (ATP mol O2
1). Increasing rates of ATP turnover have
a feedforward effect on rates of muscle glycogenolysis through a decrease in
cellular energy charge.
Cell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc. 167
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2003).
Free amino acid flux during exercise reflects dynamic activity
in de novo synthesis, transamination, deamination, oxidation,
and irreversible catabolism of specific amino acids. Several
amino acids (alanine, aspartate, glutamate, glutamine, and the
branched-chain amino acids [BCAAs] valine, leucine, and isoleu-
cine) contribute to energy production in skeletal muscle (Gibala,
2006), whereas other amino acids contribute to gluconeogenesis
during prolonged exercise (Ahlborg et al., 1974). Calculations of
substrate utilization during exercise generally assume that the
contribution of protein is constant, or alternatively use a nonpro-
tein respiratory exchange ratio (RER). Protein-based energy
provision during moderate intensity exercise is estimated at
5%–15%, while energy-compromised states, such as glycogen
depletion, demand higher contributions (Wagenmakers et al.,
1991; Horton et al., 1998). This energy is obtained from intra-
muscular protein degradation and oxidation of BCAAs by the
branched-chain a-keto acid dehydrogenase complex (Wagen-
makers et al., 1991).
Substrate Metabolism during the Postexercise
Recovery Period
After the cessation of exercise, the metabolic rate declines but
remains slightly elevated (<10%) for up to 24 hr. The extent of
this ‘‘excess postexercise oxygen consumption’’ (EPOC) is
proportional to the metabolic stress and determined by the
intensity, duration, and type of exercise bout (Børsheim and
Bahr, 2003). This recovery period is characterized by two major
phases: (1) recovery of myocellular homeostasis in the imme-
diate hours after exercise, and (2) cellular contributions to
adaptation to exercise. Moreover, the global restitution of
homeostasis includes the replenishment of oxygen stores,
resynthesis of ATP and phosphocreatine (PCr), lactate oxidation
and removal, restoration of fluid balance and fuel stores, and
inflammatory and anti-inflammatory responses (Børsheim and
Bahr, 2003). In contrast to the reliance on CHO metabolism
during exercise, an increase in lipid oxidation and ‘‘sparing’’ of
CHO sources for energy provision occurs during the recovery
period (Kiens and Richter, 1998). This shift accommodates the
highmetabolic priority for muscle glycogen resynthesis, whereas
the oxidation of lipid fromboth IMTG and circulating FFA sources
is elevated to meet fuel requirements. The prolonged elevation
in lipid oxidation in the postexercise period represents a key
event in exercise-mediated effects on whole-body lipid meta-
bolism. Lipid oxidation rates can reach 25% of that reported
during exercise, and contribute greater than 60% of oxidative
metabolism during recovery (Horton et al., 1998). Several other
biosynthetic processes contribute to homeostatic recovery
at a local level, including elevated rates of mitochondrial and
myofibrillar protein synthesis (Wilkinson et al., 2008), lipid rees-
terification of previously liberated FFAs (Wolfe et al., 1990),
and IMTG and glycogen resynthesis (Kiens and Richter, 1998;
Schenk and Horowitz, 2007). These largely anabolic events are
dichotomous to the catabolic nature of acute exercise.
In contrast to the rapid glycogen depletion during heavy or
prolonged exercise, the replenishment of muscle glycogen to
pre-exercise levels requires 24–48 hr. This timeline is readily
altered by dietary manipulation. High CHO intake often produces
a ‘‘supercompensation’’ effect such that glycogen repletion168 Cell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc.markedly exceeds pre-exercise concentrations. Replenishment
of muscle glycogen stores is primarily dependent on (1) the
availability of substrates, both glucose and nonglucose sources
including lactate and alanine, and (2) noninsulin- and insulin-
dependent enzymatic activity of glycogen synthase (Jentjens
and Jeukendrup, 2003). Similarly, IMTG replenishment via
skeletal muscle lipogenesis is influenced by both nutrient status
and activation of triglyceride synthesis via mGPAT, DGAT, and
SCD1 (Schenk and Horowitz, 2007). Lipid intermediaries such
as diacylglycerol (DAG) and ceramides are reduced in skeletal
muscle after exercise, suggesting their incorporation into IMTG
during recovery (Schenk and Horowitz, 2007).
Contraction-Induced Signal Transduction Pathways
in Skeletal Muscle
Contraction-induced changes in mechanical strain, ATP turn-
over, calcium flux, redox balance, reactive oxygen species
(ROS) production, and intracellular oxygen pressure have all
been implicated in the activation of signal transduction cascades
regulating skeletal muscle plasticity (Figure 4). In turn, various
cellular sensors transduce these homeostatic perturbations to
couple contraction and transcriptional processes. The nature
of the exercise challenge determines the acute metabolic and
molecular responses, which are latterly contiguous with long-
term physiological adaptation of exercise training. This provides
a framework, known as excitation-transcription coupling, for the
continuity and integration between signaling events regulated by
cellular bioenergetics and the expression of genes that dictate
skeletal muscle phenotype.
Local Tissue Oxygenation and Hypoxia-Inducible
Factors
Oxygen sensing is long established in the regulation of adaptive
processes in cells. The major signal transduction pathway sensi-
tive to the intracellular partial pressure of oxygen (PiO2) is regu-
lated through hypoxia-inducible factor (HIF), a heterodimeric
transcription factor composed of two subunits, HIF-1a and
HIF-1b. Under normoxic conditions, hydroxylation of HIF-1a
occurs by prolyl hydroxylase (PHD) enzymes which act as
sensors of cellular oxygen tension. This triggers the binding of
the E3 ubiquitin ligase von Hippel Lindau tumor-suppressor
protein (pVHL) to HIF-1a and targets it for proteasomal degrada-
tion (Maxwell et al., 1999). During hypoxia or conditions of
reduced PiO2, the hydroxylase activity of PHD enzymes is in-
hibited, allowing stabilization of HIF-1a, which translocates to
the nucleus to form an active complex with HIF-1b. Activation
of HIF-1 induces transcription of target genes involved in eryth-
ropoiesis, angiogenesis, glycolysis, and energy metabolism
(Taylor, 2008) in a manner analogous to exercise (Mahoney
et al., 2005; Schmutz et al., 2006). HIF-dependent transcriptional
regulation augments survival during low O2 tension either by
increasing O2 delivery and extraction or by enhancing the ability
to obtain ATP from O2-independent pathways. HIF-1 activates
transcription by binding to hypoxia response elements within
target genes and recruiting transacting coactivators such as
p300 and CBP (CREB-binding protein) (Jiang et al., 1996).
Although the PiO2 in resting skeletal muscle is 1/5th of the
oxygen pressure of inhaled air, acute exercise reduces PiO2 in
contracting muscle to 1/40th of that of inhaled air (Richardson
et al., 1995). Unsurprisingly, HIF-1a protein abundance is
Figure 4. Schematic of Excitation-Transcription Coupling in Skeletal Muscle
The onset of myofibrillar activity via shortening (concentric) and lengthening (eccentric) contractions during exercise results in a milieu of biochemical and
biophysical stimuli localized within the contracting muscle. These perturbations in skeletal muscle homeostasis lead the activation of networks of signaling
molecules including protein kinases, phosphatases, and deacetylases, which are integrated into physiological processes by downstream targets, including
transcription factors and transcriptional coregulators. These events occur in a temporal manner, such that kinase activation and pretranscriptional regulation
occur rapidly during exercise and recovery, whereas transcript alterations are subsequently observed. The relative activation, contribution, andmagnitude of the
described pathways and downstream targets are dependent on the intensity, duration, and mode of the exercise stimulus, and on imposed environmental
variables. Here, linear pathways are depicted, but in fact, these pathways demonstrate some degree of dependence, crosstalk, interference, and redundancy in
their regulation, making the exact contribution of each signaling pathway to measured changes in gene expression difficult to isolate. A multiple signal trans-
duction-to-transcription-coupled control system with inherent redundancy allows for fine-tuning of the adaptive responses to exercise training.
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and shows enhanced DNA binding, coincident with a decrease
in pVHL expression (Ameln et al., 2005). HIF-related processes
are relevant to exercise-induced skeletal muscle metabolism
and adaptation (Mason et al., 2004; Formenti et al., 2010) and
likely regulate the beneficial effects of simulated altitude training
practiced by athletes (Vogt et al., 2001).
Cellular Energy Status, ATP Turnover, and AMP-
Activated Protein Kinase Signaling
AMP-activated protein kinase (AMPK) is a serine/threonine
kinase that modulates cellular metabolism acutely through
phosphorylation of metabolic enzymes (Carling and Hardie,
1989) and, over time, via transcriptional regulation (Bergeron
et al., 2001; Ja¨ger et al., 2007). AMPK activation is regulated
allosterically by a cellular energy deficit, which is reflected by
increases in the AMP/ATP and Cr/PCr ratios (Kahn et al.,
2005). In addition to intense exercise (Green et al., 1992; Howlettet al., 1998), cellular stresses that deplete ATP (such as meta-
bolic poisons) or increase the cellular AMP/ATP ratio (such as
glucose deprivation or oxidative stress) also activate AMPK
(Kahn et al., 2005). Given the rate of ATP turnover during muscle
contraction, AMPK acts as a signal transducer for metabolic
adaptations by responding to an altered cellular energy status.
Acute exercise increases AMPK phosphorylation and enzymatic
activity in an intensity-dependent manner (Wojtaszewski et al.,
2000; Egan et al., 2010), reflecting intensity-dependent effects
of exercise on ATP turnover and adenine nucleotide concen-
trations (Howlett et al., 1998).
Overall, AMPK activation acts to conserve ATP by inhibiting
biosynthetic pathways and anabolic pathways, while simulta-
neously stimulating catabolic pathways to restore cellular energy
stores (Kahn et al., 2005). In skeletal muscle, acute AMPK acti-
vation suppresses glycogen synthesis (Carling and Hardie,
1989) and protein synthesis (Bolster et al., 2002), but promotesCell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc. 169
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(Winder and Hardie, 1996). Chronic AMPK activation alters
metabolic gene expression and induces mitochondrial biogen-
esis (Bergeron et al., 2001), partly via AMPK-inducedmodulation
of the DNA binding activity of transcription factors including
NRF-1, MEF2, and HDACs (Bergeron et al., 2001; McGee
et al., 2008).
Calcium Flux and Calcium/Calmodulin-Dependent
Protein Kinase Signaling
Calcium is essential for facilitating the crossbridge interaction
betweenmyosin and actin duringmyofibrillar contraction. During
contraction, calcium oscillations, whose amplitude and duration
are a function of the level of force output by the muscle, are
translated into discrete signals that modulate the kinase activity
of calmodulin-dependent protein kinases (CaMKs), a class of
multifunctional serine/threonine protein kinases implicated in
muscle plasticity (Chin, 2010). CaMKII is the dominant isoform
in human skeletal muscle (Rose et al., 2006). Exercise increases
CaMKII phosphorylation in an intensity-dependent manner
(Rose et al., 2006; Egan et al., 2010), possibly due to additional
muscle fiber recruitment (Sale, 1987) or to higher calcium
concentrations expected at greater force outputs (Howlett
et al., 1998). Intensity-dependent CaMKII activation may func-
tion as a stimulation-frequency decoder (Chin, 2010). Thus,
calcium signaling is sensitive to different types of contraction
(i.e., aerobic versus resistance) and could, based on the relative
amplitude and frequency of calcium transients depending on the
contractile stimulus, thereby result in dramatically different
signal transduction patterns (Dolmetsch et al., 1997).
CaMKs and calcium signaling influence glucose transport
(Wright et al., 2004), lipid uptake and oxidation (Raney and
Turcotte, 2008), and skeletal muscle plasticity (Wu et al., 2002).
Transcription factors, such as CREB, MEF2, and HDACs, are
CaMK targets implicated in the regulation of skeletal muscle
gene expression. For instance, the activation of CaMKII leads
to phosphorylation and nuclear exclusion of HDAC4, which
relieves repression of MEF2 (Liu et al., 2005). This model couples
contraction-induced calcium signaling to an increased rate of
transcription of MEF2 target genes such as PGC-1a and
GLUT4 (Chin, 2010).
Mechanical Stress and Mitogen-Activated Protein
Kinase Signaling
Growth factors, cytokines, and cellular stress impact the activity
of the mitogen-activated protein kinase (MAPK) family. Presum-
ably because of the wide variety of biochemical and biophysical
processes activated by muscle contraction, acute exercise acti-
vates threemainMAPK subfamilies in human skeletal muscle: (1)
the extracellular-regulated kinase (ERK1/2), (2) c-jun N-terminal
kinase (JNK), and (3) p38 MAPK. The level of p38 MAPK activa-
tion is dependent on exercise status (Yu et al., 2003; Coffey et al.,
2006b), while the predominance of eccentric or concentric
contractions can influence other MAPK activation patterns
(Wretman et al., 2001). MAPKs regulate transcriptional events
by phosphorylation of diverse substrates localized in the cyto-
plasm or nucleus, including transcription factors and coactiva-
tors, and thereby regulate a variety of physiological processes
such as differentiation, hypertrophy, inflammation, and gene
expression (Long et al., 2004). For example, during contraction,
p38 MAPK can stimulate upstream transcription factors of the170 Cell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc.PGC-1a gene, such as ATF2 and MEF2 (Table 3) (Akimoto
et al., 2005), which coincides with an increase in PGC-1a ex-
pression (Akimoto et al., 2005; Wright et al., 2007; Egan et al.,
2010). Constitutive activation of p38 MAPK increases markers
of mitochondrial adaptation in skeletal muscle (Akimoto et al.,
2005), whereas deletion of the p38g isoform, but not p38a or
p38b, prevents training-induced increases in mitochondrial
biogenesis and angiogenesis (Pogozelski et al., 2009).
During contraction, skeletal muscle is a potent site of ROS
production via generation of superoxides by electron transport
chain complexes I and III, and the activity of NADPH oxidase
and xanthine oxidase. ROS activate MAPK signaling and the
transcription factor nuclear factor-kB, thereby linking signal
transduction to transcriptional processes (Powers et al., 2010).
Acute exercise activates JNK signaling in a ROS-dependent
manner, as evidenced by attenuated JNK signaling during exer-
cise with infusion of the antioxidant N-acetylcysteine (Petersen
et al., 2012). Moreover, contraction-induced increases in inter-
leukin-6 (IL-6) secretion, a exercise-associated cytokine with
potent multiorgan metabolic effects (Pedersen and Febbraio,
2012), is JNK dependent (Whitham et al., 2012), which attests
to the likely importance of JNK signaling in mediating metabolic
adaptation to exercise.
Redox Balance, NAD+:NADH, and Sirtuins
NAD+ is an electron carrier that plays a critical role in fuel metab-
olism. NAD+ couples ATP synthesis with the electron transport
chain, through its reduction during glycolysis and reoxidation
by lactate generation in the cytosol or mitochondrial shuttle
activity, as well as reduction reactions of the TCA cycle. Of
interest, the regulation of the sirtuin (SIRT) family of protein de-
acetylases is NAD+ dependent (Schwer and Verdin, 2008). The
deacetylase activity of SIRT1 (cytoplasmic, nuclear) and SIRT3
(mitochondrial) is sensitive to elevations in [NAD+] and NAD+/
NADH ratio. The subsequent deacetylation of lysine residues
on transcriptional regulators (Nemoto et al., 2005) andmitochon-
drial enzymes (Hirschey et al., 2010) allows the coupling of alter-
ations in the cellular redox state to the adaptive changes in gene
expression and cellular metabolism (Lagouge et al., 2006; Canto´
et al., 2009). Enhanced SIRT activity is associated with favorable
adaptations in skeletal muscle metabolism, including enhanced
mitochondrial function, exercise performance, and protection
against obesogenic feeding (Lagouge et al., 2006; Gerhart-Hines
et al., 2007).
Dynamic fluctuations in the NAD+/NADH ratio occur in
response to stimuli such as acute exercise and fasting (Sahlin
et al., 1987; Canto´ et al., 2009). With increasing exercise inten-
sity, the cytosolic NAD+/NADH ratio declines as the lactate/
pyruvate ratio increases (Sahlin et al., 1987; Green et al.,
1992). In rodents, elevations in SIRT1 activity peak around 3 hr
into recovery (Canto´ et al., 2009), which coincides with a
dramatic elevation in the NAD+/NADH ratio, predominantly due
to an increase in [NAD+]. The aforementioned glucose sparing
during postexercise recovery coincides with an increase in
b-oxidation and reoxidation of NADH to NAD+. SIRT activation
is therefore in contrast to phosphorylation of various protein
kinases that tend to be elevated immediately after exercise,
and return rapidly to basal values. Conversely, short-term
interval training increases SIRT1 expression in skeletal muscle
(Little et al., 2010), while higher SIRT3 protein is reported in
Table 3. Evidence Base for Regulatory Roles of Signaling Molecules and Transcriptional Regulators in Skeletal Muscle Metabolic and
Mitochondrial Adaptation to Exercise
Gene or Family
Function and Evidence for Regulation of Skeletal
Muscle Phenotypea
Effect of Acute Exercise and/or Exercise Training on
Regulation and Expression in Skeletal Muscleb
ATF2 d Activated at p-Thr69/71 by p38 MAPK and interacts
with CREs present in metabolic and mitochondrial genes
d AEX: [ p-ATF2 in humans and rodents
(intensity dependent)
d DN ATF2: ablates contraction-induced increase
in PGC-1a gene transcription
d p38 MAPK effects on gene expression via p.a. or
by c.a. of MKK3/6 are ATF2 dependent
AMPK d Chronic AMPK activation by AICAR or b-GPA
feeding: [ metabolic gene expression and mtBIOG
d AEX: [ p-AMPK in humans and rodents
(intensity dependent)
d Effects abolished in AMPK a2 KO or KD mice d [ a2 AMPK activity in most AEX models
d c.a. AMPK (AMPKg1
R70Q and AMPKg3
R225Q): [ glycogen
storage, mitochondrial gene expression, and EXC
d [ a1 AMPK activity during high-intensity/sprint AEX
d Similar phenotype in HSMCs with human mutation
PRKAG3R225W
d [ p-AMPK during AEX is blunted after EXT
d LKB1 KO and AMPK a2 KO: Y basal levels of
mitochondrial genes
d AMPK a2 and g3 KO: AEX-induced changes
in gene expression attenuated, but adaptive response
to EXT is similar to WT
CaMKs d c.a. CaMKIV: [ mtBIOG, FAO/ETC gene expression,
and fatigue resistance during contraction
d AEX: [ p-CaMKII in humans and rodents
(intensity dependent)
d CaMKII inhibition: attenuates gene expression
induced by contraction or [Ca2+]-releasing agents
d EXT: [ CaMKII expression and enzymatic activity,
but [ p-CaMKII during AEX is similar
CREB d Activated by p-Ser133 by PKA, CaMKs, and AMPK
and regulates gene expression through CRE interaction
d AEX: biphasic response, Y p-CREB on exercise
cessation, [ p-CREB during recovery
(intensity dependent)
d Critical to PKA-dependent regulation of myogenesis
d DN CREB: dystrophic phenotype, Y MEF2 activity
ERRs d ERRa KO: Y FAO gene expression; ablates
ANG in response to 14 day VWR
d AEX: [ ERRa mRNA during recovery
d ERRg OE: more oxidative fibers, [ mitochondrial
enzyme activity, ANG, and EXC
d EXT: [ ERRa protein
d ERRg+/: Y mitochondrial function, FAO gene
expression, and EXC
d Data for ERRg have not been reported
FOXOs d FOXO1 KO: [ MyoD and percentage
type II fibers, Y EXC
d AEX: [ FOXO1 and FOXO3 mRNA during recovery
d FOXO1 OE: causes fiber atrophy, marked Y in
muscle mass and locomotor activity
d Resistance EXT: [ p-FOXO3 and Y FOXO1 protein
d c.a. FOXO3 drives atrophy through upregulation
of the ubiquitin ligases atrogin-1/MAFbx and MuRF1
HATs and HDACs d Combinatorial KO of HDAC isoforms (4, 5, 9): [
percentage type I fibers and oxidative gene expression
d AEX: [ p-HDAC (class IIa) in humans
(intensity dependent)
d c.a. HDAC5: ablates increase in percentage
type I and IIa fibers in response to 4 weeks VWR
d Y repressive activity of HDAC4 and 5 by
p-induced nuclear exclusion
d HDAC inhibition: variety of effects on myogenesis
and mtBIOG
d Coincides with Y HDAC-association with MEF2,
[ MEF2-PGC-1a association, and [ GLUT4
HIFs d HIF-1a mKO: Y glycolytic flux, but [ oxidative
enzyme activity, ANG, and EXC
d AEX: [ total and nuclear stabilization of HIF-1a,
Y Pvhl, and [ HIF-1a DNA binding activity
d HIF-1a OE: [ percentage type IIa fibers and fiber
CSA and Y oxidative enzyme activity
d AEX: [ HIF-1a and HIF-2a mRNA during recovery
d HIF-2a mKO: [ percentage type IIb fibers;Y percentage
type I fibers, ANG, and antioxidant gene expression
d EXT: Y HIF-1a and HIF-2a mRNA at rest
d In CP patients (HIF degradation impaired): [ mRNA
levels of PDK4, PFK, and PK; marked PCr depletion and
acidosis during exercise and Y maximal exercise capacity
d HIF-1a mKO: adaptive response to
EXT is similar to WT
(Continued on next page)
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Table 3. Continued
Gene or Family
Function and Evidence for Regulation of Skeletal
Muscle Phenotypea
Effect of Acute Exercise and/or Exercise Training on
Regulation and Expression in Skeletal Muscleb
MEF2 d MEF2 mKO: Y oxidative enzyme activity and
percentage type I fibers
d AEX: [ MEF2 nuclear abundance and DNA
binding activity
d c.a. MEF2: [ percentage type I fibers, markers
of oxidative metabolism including myoglobin
and PGC-1a and doubles EXC
d AEX: [ nuclear association of MEF2 with PGC-1a
and p-p38 MAPK
NRFs d NRF-1 mOE: [ GLUT4 and oxidative gene expression,
but muscle respiratory capacity is unchanged
d AEX: [ NRF-1 and NRF-2 mRNA during recovery
in rodents, but results are equivocal in humans
d DN NRF-2: Y COX expression d AEX: [ DNA binding activities of NRF-1 and NRF-2
(to cyt c and COXIV promoters, respectively)
d NRF-2 shRNA: Y expression of all ten
nucleus-encoded COX subunits
p38 MAPK d c.a. MKK3/6 upstream of p38 MAPK [ PGC-1a
transcription; effect ablated by DN p38 MAPK
or p38 inhibition
d AEX: [ p-p38 MAPK in response to cycle and running
d c.a. MKK6: [ PGC-1a and COXIV in type II fibers d Level of activation is dependent on training status
d p38g, but not p38a or p38b, mKO: attenuates
ANG and [ mitochondrial gene expression
after 4 weeks VWR
d EXT: [ p-p38 MAPK during unaccustomed exercise,
i.e., aerobic-trained perform resistance,
or resistance-trained perform aerobic
d Alterations in fiber characteristics after
4 weeks VWR similar in all mKOs
PPARs d PPARd agonists (4 week): [ FAO gene expression
and oxidative profile of type II fibers
d AEX: [ PPARd mRNA during recovery
d PPARd agonist combined with 4 weeks EXT:
greater [ in oxidative gene expression and
EXC compared to EXT alone
d EXT: [ PPARd mRNA after 16 weeks of
low-intensity EXT
d c.a. PPARd: [ percentage type I fibers, oxidative
gene expression, mtBIOG, and EXC
d PPARd mOE mice: [ state 3 respiration and
performance during sprint-type exercise
PGC Family d PGC-1a OE in muscle cells: [ mtDNA copy number,
mtBIOG, and respiratory capacity
d AEX: [ in PGC-1a mRNA during recovery
(intensity dependent)
d PGC-1b and PRC OE: similar effects; also important for
antioxidant and anti-inflammatory processes, respectively
d AEX: stabilizes PGC-1a protein, [ PGC-1a activity
(de-Ac), and subcellular localization to the nucleus
and mitochondrion
d PGC-1a mOE: [ mtBIOG, respiratory capacity, and
antioxidant defense in type II fibers and [ EXC
d EXT: [ PGC-1a protein in health and disease
d PGC-1a mKO: fibers with [ glycolytic phenotype,
Y mitochondrial respiration, EXC and recovery from AEX
d PGC-1a mKO: adaptive response to EXT is similar
to WT in most parameters except ANG, which is ablated
d PGC-1a/b dKO: similar derangements, but in the
absence of changes in fiber type proportions
RIP140 d Transcriptional corepressor acting as scaffold protein
recruiting chromatin-remodeling enzymes
d AEX: [ RIP140 mRNA during recovery
d RIP140 KO: [ mitochondrial oxidative capacity,
gene expression, and percentage type IIa/x fibers
at expense of type IIb
d EXT: RIP140 protein or mRNA unchanged
d RIP140 OE: Y SDH activity and myoglobin in
type II fibers
d RIP140 OE: adaptive response to 6 weeks
VWR is similar to WT
SIRTs d SIRT1 activation with resveratrol: [ oxidative gene
expression and capacity, mtBIOG, and EXC
d AEX: [ SIRT1 mRNA, protein, and enzymatic activity
d SIRT1 mKO and SIRT3 mKO: no obvious
muscle phenotype
d EXT: [ SIRT1 mRNA, protein, and enzymatic activity
d SIRT1 mKO: PGC-1a de-Ac after AEX is similar to WT d EXT: [ SIRT3 mRNA and protein
d SIRT3 KO: Y mitochondrial capacity
and [ oxidative stress
d SIRT1 mKO: adaptive response to 3 weeks
VWR is similar to WT
(Continued on next page)
172 Cell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc.
Cell Metabolism
Review
Table 3. Continued
Gene or Family
Function and Evidence for Regulation of Skeletal
Muscle Phenotypea
Effect of Acute Exercise and/or Exercise Training on
Regulation and Expression in Skeletal Muscleb
Tfam d Tfam mKO: [ mitochondrial myopathy and
ragged-red fibers
d AEX: [ Tfam mRNA during recovery
d Compensatory [ in mitochondrial mass maintain
normal rates of ATP generation
d AEX: [ mitochondrial PGC-1a-Tfam bound
to mtDNA D loop
d Rates of fatigue development similar to WT,
but Y force-generating capacity
d EXT: [ Tfam mRNA and protein
Models included in the table are based on demonstration of phenotype related to skeletal muscle fiber characteristics, or the molecular response
to exercise and/or training, when compared to noninduced or wild-type (WT) counterparts. [, increases; Y, decreases; +/, heterozygous; Ac-, acet-
ylation; AEX, acute exercise; ANG, angiogenesis; c.a., constitutive activation; CaM, calmodulin; CP, Chuvash polycythemia; DN, dominant-negative;
ETC, electron transport chain; EXC, endurance exercise capacity; EXT, exercise training; FAO, fatty acid oxidation; HSMCs, human skeletal muscle
cells; KD, kinase-dead; KO, knockout; OE, overexpression; MKK, MAPK kinase; mKO, skeletal muscle-specific KO; mOE, skeletal muscle-specific
OE; p-, phosphorylation; VWR, voluntary wheel running.
aEvidence refers to transgenicmousemodels in vivo, and/or in vitro manipulation in muscle cells, unless otherwise stated. In vivo and in vitro models of
hypertrophic regulation are described elsewhere (Schiaffino and Reggiani, 2011).
bAerobic exercise unless otherwise stated.
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2008). Interestingly, a reduction in SIRT3 expression has been
implicated in the development of skeletal muscle insulin resis-
tance (Jing et al., 2011). This raises the possibility that exer-
cise-induced increases in SIRT3 and associated effects on
mitochondrial function may partially explain the therapeutic
effects of exercise. Whether changes in SIRTs and NAD+metab-
olism are causative factors or occur in parallel with remodeling of
skeletal muscle by exercise training remains to be clarified.
High-Force Stimuli and Mechanosensory Signal
Transduction
All forms of muscular contraction result in the application of
tension (force) through an active muscle. However, the adaptive
muscle growth (hypertrophy) consequent to high mechanical
loads present during resistance exercise is largely determined
by the activation of skeletal muscle protein synthesis (MPS)
consequent to the activation of mTOR, ribosomal protein S6K
(p70S6K), and downstream targets (Bodine et al., 2001). p70S6K
is a key regulator of MPS through canonical pathways of protein
translation and ribosome biogenesis involving eukaryotic trans-
lation initiation factor 4E (eIF4E) binding protein (4E-BP1) and
elongation factor 2 (eEF2). Phosphorylation of 4E-BP1 by
mTOR suppresses binding and inhibition of eIF4E by 4E-BP1.
This derepression allows eIF4E to directly bind the 50 end of
mRNA to ultimately form an active eIF4F complex, a rate-limiting
step in translation initiation. Phosphorylation of S6K leads to the
phosphorylation of the 40S ribosomal protein S6 (rpS6) and
eIF4B. Collectively these events lead to the formation of the
translation initiation complex and activate protein synthesis for
cellular hypertrophy (Sandri, 2008).
Mechanosensory regulation of MPS is determined by high-
force contractions during resistance-type exercise (Philp et al.,
2011). Such contractions transiently disrupt the sarcolemma
(the lipid bilayer that surrounds a muscle cell), which increases
the concentration of membrane phospholipid phosphatidic
acid (PA) through activation of phospholipase D (PLD). PA acti-
vates mTOR through interaction with its FRB domain (Fang
et al., 2001), resulting in the activation of mTOR and MPS
(O’Neil et al., 2009). Conversely, a contraction-induced increasein PA and mTOR activation is attenuated in the presence of
PLD inhibition (Hornberger et al., 2006; O’Neil et al., 2009).
Mechanosensory regulation of MPS also involves focal adhesion
kinase (FAK) proteins, a class of transmembrane receptors that
act as protein tyrosine kinases. FAK proteins are key elements
for the transmission of contractile force through the skeletal
muscle architecture and a central component of integrin
signaling. The expression and activity of FAK in skeletal muscle
are related to the relative loading (Klossner et al., 2009; Durieux
et al., 2009), and contraction results in conformational changes
and activation of FAK phosphotransferase activity (Wilkinson
et al., 2008; Klossner et al., 2009), which can activate MPS
through mTOR-dependent and -independent mechanisms
(Philp et al., 2011).
Molecular Regulation of the Endurance Phenotype
Aerobic Exercise—Metabolic and Mitochondrial
Adaptations
Mitochondrial biogenesis is a well-established response to
aerobic exercise training (Howald et al., 1985) and is defined by
an increase in muscle mitochondrial number and volume,
as well as concomitant changes in organelle composition. In
response to increased contractile activity, half-lives of approxi-
mately 1 week are observed for mitochondrial proteins (Booth,
1977; Henriksson and Reitman, 1977). After 6 weeks of exercise
training, muscle mitochondrial density increases 50%–100%
(Hood, 2001). Changes occur in all three fiber types, with the
difference being somewhat greater in type IIa than in type I and
type IIx fibers (Howald et al., 1985). Improvements in exercise
performance during the same time frame outpace the relatively
small (typically 5%–20%) increases in whole-body aerobic fit-
ness measured by maximal oxygen uptake (VO2max), and reflect
enhancements in the intrinsic oxidative capacity of muscle, and
the delivery and utilization of substrates in working muscle
during subsequent exercise bouts (Phillips et al., 1996; Vollaard
et al., 2009). Specifically, these metabolic adaptations reflect
increased abundance of proteins involved in mitochondrial ATP
production (Holloszy, 1967), the TCA cycle (Egan et al., 2011),
mobilization, transport and oxidation of fatty acids (TalanianCell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc. 173
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idant capacity (Powers et al., 1994), glucose transport and
glycogen synthesis (Perseghin et al., 1996), and oxygen delivery
to and extraction from skeletal muscle (Gavin et al., 2007).
Training-induced increases in metabolic enzyme activities
and mitochondrial density result in enhanced respiratory control
sensitivity such that a lower [ADP] is required to achieve the
same level of oxygen consumption per gram of muscle. Thus,
the same cellular rate of oxidative metabolism is attained with
less perturbation of adenine nucleotides and a lower rate of
oxidative phosphorylation per mitochondrion (Holloszy and
Coyle, 1984; Dudley et al., 1987). After training, smaller declines
in [ATP] and [PCr], and smaller increases in free [ADP], are
observed at the same absolute power output in muscle with
increased mitochondrial density (Dudley et al., 1987; Phillips
et al., 1996). This reduces the formation of AMP, IMP, Pi, and
ammonia and thereby attenuates the allosteric regulation of
the rates of glycogenolysis and glycolysis (and lactate produc-
tion) after training, concomitant with an increase in the fraction
of ATP provision from oxidative metabolism. Enhanced respira-
tory control sensitivity coupled to decreased flux through
glycogen phosphorylase and attenuated exercise-induced acti-
vation of PDH (Leblanc et al., 2004) results in a reduction of CHO
utilization after training, whereas the overall capacity for lipid
oxidation is markedly increased (Talanian et al., 2010). Conse-
quently, decreased CHO utilization during exercise in the trained
state is compensated for by a proportional increase in lipid
oxidation rates at the same absolute and relative intensity (Hol-
loszy and Coyle, 1984). Thus, increased endurance performance
observed after training is attributed to enhanced fatigue resis-
tance by virtue of reduced muscle glycogen depletion, tighter
coupling of ATP supply and demand, and, thereby, smaller
disturbances to homeostasis combined with a consequent
reduction in metabolic byproducts.
Regulation of Skeletal Muscle Gene Expression
and Adaptation
An increasingly well-defined network of transcription factors and
coregulator proteins has emerged that regulates the skeletal
muscle phenotype by integrating signals from physiological
stimuli and coordinating metabolic adaptation (Figure 5). This
network exerts molecular control over contractile, metabolic,
and mitochondrial adaptation, illustrated by an ability to alter
the expression of key enzymes in CHO and lipid metabolism,
and the coordination of myogenesis and mitochondrial biogen-
esis in response to exercise (Hood, 2001; Flu¨ck and Hoppeler,
2003; Coffey and Hawley, 2007). The process of mitochondrial
biogenesis is complex and highly regulated, requiring the co-
ordination and coexpression of both the nuclear and the mito-
chondrial genomes for the assembly and expansion of the
reticulum, and the generation of a dynamic mitochondrial
network. Appropriate synchronization includes the transcription
of nuclear genes, translation of newly formedmRNAs and import
of proteins into mitochondria, replication of mitochondrial DNA
(mtDNA), transcription and translation of mitochondrial genes,
biosynthesis of mitochondrial membrane phospholipids, and
assembly of the enzyme complexes (Essig, 1996; Hood, 2001).
For instance, nuclear-encoded mitochondrial proteins are
chaperoned to the mitochondrion, imported into the different
organelle compartments, and assembled with mtDNA-encoded174 Cell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc.proteins to form multisubunit enzyme complexes required for
oxygen consumption and ATP synthesis.
Mechanistic studies using transgenic animals and pharmaco-
logical manipulation have explored the roles of key regulators
of skeletal muscle phenotype (Table 3). Many regulators are
sufficient to stimulate mitochondrial biogenesis, fiber-type
transformation, and reprogramming of skeletal muscle metabo-
lism, but many are not necessary for exercise-induced skeletal
muscle adaptation. For example, PGC-1a acts as a transcrip-
tional coactivator through recruitment and coregulation of mul-
tiple transcription factors that regulate skeletal muscle gene
expression, including NRF-1, NRF-2, ERRa, and Tfam (Lin
et al., 2005). PGC-1a activity is highly regulated by numerous
posttranslational modifications including phosphorylation and
deacetylation (Puigserver et al., 2001; Ja¨ger et al., 2007; Canto´
et al., 2009). Key upstream kinases and deacetylases regulating
these modifications are activated by acute exercise (Wright
et al., 2007; Canto´ et al., 2009; Egan et al., 2010), coincident
with alterations in protein stability, functional activity, and
subcellular localization (Little et al., 2011; Safdar et al., 2011b).
Ectopic expression of PGC-1a in muscle cells increases mtDNA
expression and mitochondrial biogenesis (Wu et al., 1999),
whereas altering the activity of PGC-1a inducesmolecular adap-
tations that equip the cell to meet the energy demands of
a changing environment, including augmentation of cellular
respiration rates and substrate utilization (Wu et al., 1999;Wende
et al., 2007). Overexpression of PGC-1a in rodent skeletalmuscle
produces a phenotype remarkably similar to aerobically trained
muscle, illustrated by increased mitochondrial density, respira-
tory capacity, ATP synthesis, antioxidant defense in type II
muscle fibers, and improved exercise performance (Wende
et al., 2007; Calvo et al., 2008). In muscle-specific PGC-1a KO
mice,many of these adaptations are reversed, e.g.,muscle fibers
exhibit a more glycolytic phenotype, impaired mitochondrial
respiratory function, reduced exercise capacity, and impaired
recovery from exercise (Handschin et al., 2007; Wende et al.,
2007). However, after exercise training, the adaptive increases
in myoglobin, metabolic gene expression, and mitochondrial
biogenesis are similar to those of wild-type animals (Leick
et al., 2008; Geng et al., 2010), whereas training-induced
changes in mitochondrial enzyme expression are only modestly
reduced (Geng et al., 2010). Notably, exercise-induced angio-
genesis is blunted in PGC-1a KO mice (Chinsomboon et al.,
2009; Geng et al., 2010). Therefore, despite robust effects on
skeletal muscle phenotype, PGC-1a is not necessary for the
majority of adaptive responses to exercise training.
Several proteins have established roles in the regulation of
mitochondrial biogenesis and metabolic gene expression in
skeletal muscle (Table 3), but a paucity of information exists
regarding the causal involvement of these molecules in exer-
cising human skeletal muscle beyond transient, but robust,
changes in expression after a single bout of exercise (Pilegaard
et al., 2003; Cartoni et al., 2005) or exercise training (Perry et al.,
2010). However, exercise-induced modulation of these path-
ways is still proposed to be critical to skeletal muscle adaptation
and modulation of the mitochondrial phenotype (Hood, 2001;
Flu¨ck and Hoppeler, 2003; Coffey and Hawley, 2007). Dysfunc-
tional mitochondria have been implicated in sarcopenia (Bua
et al., 2002) and insulin resistance (Lowell and Shulman, 2005),
Figure 5. Transcriptional Regulators of Metabolism and Adaptation in Skeletal Muscle
Transcription factors and coregulator proteins can be activated or induced in response to specific cellular signals, cocomplex with a variety of other factors, and/
or demonstrate selective activation of specific gene promoters containing binding sites for the given transcription factor. Apart from being crucial to the regulation
of gene expression in response to cellular signals, coregulator proteins can be primary targets for contraction-induced signal transduction pathways (Figure 4).
Regulation of this transcriptional activity occurs via change in the protein content, subcellular localization, or activity (e.g., posttranslational modifications) of
transcriptional regulators. Transcription factors, nuclear receptors, and their transcriptional coregulators integrate contractile stimuli into molecular re-
programming. The interactions of transcriptional coregulators with their cognate transcription factor targets are shown linked to specific adaptive outcomes.
These target interactions are not exclusive, and other factors are likely to contribute to a given adaptive program. CREB, cyclic AMP response element binding
protein; ERR, estrogen-related receptor; FOXO1, forkhead transcription factor, O box subfamily; GEF, GLUT4 enhancer factor; HDAC, histone deacetylase; HIF,
hypoxia-inducible factor; MEF2, myocyte enhancer factor 2; MRFs, myogenic regulatory factors; mtDNA, mitochondrial DNA; MyoG, myogenin; NRF, nuclear
respiratory factor; PGC-1, PPARg coactivator 1; PPAR, peroxisome proliferator-activated receptor; PRC, PGC-1-related coactivator; RIP140, nuclear receptor
interacting protein 1; Tfam, mitochondrial transcription factor A; VEGF, vascular endothelial growth factor. p, phosphorylation; Ac, acetylation.
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related declines in health that occur as a function of mtDNA
mutations, as recently demonstrated in mtDNA mutator mice
(Safdar et al., 2011a). Thus, mitochondrial biogenesis and
adaptation with regular exercise are now recognized to have
implications for a broader range of health issues, rather than
only the enhancement of exercise performance.
Molecular Regulation of the Hypertrophy Phenotype
Resistance Exercise—Myofibrillar Adaptation and
Adaptive Hypertrophy
Resistance exercise training elicits a range of morphological and
neurological adaptations that contribute to changes in musclefunction with respect to size, strength, and power (Booth and
Thomason, 1991; Folland and Williams, 2007). Muscle hyper-
trophy refers to an increase in muscle size, whereas strength
refers to the capacity to move an external load but is related to
muscle size. These adaptations can support improvements in
athletic performance but also improve health-related musculo-
skeletal function and offset loss of muscle and strength in
pathological states (Macaluso and De Vito, 2004). The major
morphological adaptations include (1) an increase in muscle
crosssectional area (CSA), often preferentially occurring in type
IIa fibers (Adams et al., 1993), (2) a change in the angle of
pennation of individual muscle fibers, and (3) increases in the
proportion of noncontractile tissue such as collagen (FollandCell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc. 175
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muscle strength via improvements in motor unit activation, firing
frequency, and synchrony of high-threshold motor units (Sale,
1988). Neural adaptations occur rapidly and tend to precede
hypertrophic adaptations (Moritani and deVries, 1979), which
occur at a slower rate since the rate of muscle protein synthesis
must exceed degradation for an extended period of time before
accretion of contractile protein occurs (Wong and Booth, 1990).
An acute bout of resistance exercise results in an increased rate
ofmixed,mitochondrial, andmyofibrillar protein synthesis during
recovery (Biolo et al., 1995; Phillips et al., 1997; Wilkinson et al.,
2008) and a proportionately smaller increase in the protein
degradation rate (Biolo et al., 1995). The net protein synthetic
response is critical to exercise-induced skeletal muscle adap-
tation and is the mechanistic basis for adaptive hypertrophy
(Rennie et al., 2004).
Regulation of Skeletal Muscle Protein Synthesis by
Contraction
During the exercise-induced adaptive hypertrophy response,
the control of protein translation and synthesis drives protein
accretion, while the activation and incorporation of satellite
cells facilitate the addition of newly formed myofibrils to the
contractile machinery. Due to the importance of protein
synthesis exceeding breakdown over an extended period of
time, the degree of muscle hypertrophy induced by resistance
exercise is strongly associated with the degree of p70S6K phos-
phorylation (Baar and Esser, 1999; Terzis et al., 2008). Contrac-
tion-induced p70S6K activation is dependent on mTOR, which
integrates nutrient and metabolic stimuli to regulate cell growth
and proliferation. Activation of this pathway by contraction
through the aforementioned mechanosensory pathway drives
translational processes, increases the rate of MPS, and medi-
ates muscle hypertrophy through protein accretion (Rennie
et al., 2004). mTOR activation is critical to load-induced muscle
growth, as demonstrated by the attenuation of hypertrophic
responses and protein synthesis by the mTOR inhibitor, rapa-
mycin (Bodine et al., 2001). The mTOR pathway controls
mechanisms of protein synthesis at several levels (e.g., transla-
tion capacity, translation efficiency) through increases of trans-
lation of specific mRNAs, which culminate in skeletal muscle
fiber enlargement. mTOR exists as part of two multiprotein
complexes: mTORC1, which contains raptor and confers
rapamycin sensitivity, is required for signaling to p70S6K and
4E-BP1, whereas mTORC2, which contains rictor and is rapa-
mycin insensitive, is required for signaling to Akt-FOXO (Sandri,
2008). The effect of mTOR activity on downstream regulators of
protein synthesis is principally achieved through contraction-
induced regulation of mTORC1 (Philp et al., 2011). Early work
on adaptive hypertrophy focused on the (transient) postexer-
cise rise in blood-borne anabolic hormones such as growth
hormone and insulin-like growth factor (IGF)-I, and consequent
activation of a signaling cascade through phosphatidylinositol
3-kinases (PI3K)-Akt-mTOR by IGF-I interaction with insulin
and IGF receptors (Adams and McCue, 1998). Recently, the
muscle growth paradigm has shifted focus to IGF-I-indepen-
dent mechanisms of mTOR activation and adaptive hyper-
trophy through mechanosensory regulation (Philp et al.,
2011). Nutrient-dependent regulation of muscle growth is
achieved through insulin- and Akt-dependent activation of the176 Cell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc.mTOR pathway. These pathways exhibit synergy to promote
muscle growth in athletes and disease states and can be
augmented by appropriate nutritional intake such as postexer-
cise CHO and amino acid ingestion or increased dietary protein
(Rennie et al., 2004).
Regulation of Skeletal Muscle Protein Degradation
The regulation of skeletal muscle protein degradation is primarily
dependent on the activity of the ubiquitin-proteasome pathway.
This occurs via two muscle-specific E3 ubiquitin ligases, muscle
atrophy F box (atrogin-1/MAFbx) and muscle RING finger 1
(MuRF1), which are key regulators of skeletal muscle proteolysis
under catabolic conditions (Sandri, 2008). For instance, MHC
degradation is regulated by MuRF1-dependent ubiquitination
(Clarke et al., 2007). In this model, activation (dephosphorylation)
of FOXO transcription factors leads to the transcriptional upre-
gulation of MAFbx/atrogin-1 and MuRF1 (Sandri et al., 2004).
The translocation and activation of FOXO members are neces-
sary for the upregulation of atrogin-1/MAFbx and MuRF1,
whereas FOXO3 is sufficient to promote atrogin-1/MAFbx
expression and muscle atrophy in vivo (Sandri et al., 2004).
FOXO activity is primarily regulated by posttranslational
modifications that determine its subcellular localization, i.e.,
phosphorylation by Akt promotes nuclear export of FOXOs to
the cytoplasm. Therefore, Akt acts as a critical node at the
balance of muscle protein synthesis and degradation. The role
of this pathway is firmly established in muscle atrophy but less
well established with respect to protein breakdown during adap-
tive hypertrophy, or to transient changes in protein turnover
during and after a single bout of exercise. Acute exercise studies
that examine proteolytic gene expression in response to either
aerobic or resistance exercise show MuRF1 mRNA expression
to be elevated 2–4 hr into recovery, whereas atrogin-1/MAFbx
mRNA tends to be elevated early in recovery and decreased later
(>12 hr) into recovery (Coffey et al., 2006a; Louis et al., 2007). The
induction pattern of these proteolytic genes corroborates well
with the biphasic response of muscle protein degradation
following resistance exercise (Phillips et al., 1997), although the
direct link between these phenomena has not been established
in vivo.
Role of Skeletal Muscle Satellite Cells in Adaptive
Hypertrophy
While the role of satellite cells in muscle regeneration is well
established, the role of satellite cells in hypertrophy of adult
skeletal muscle is debated (O’Connor et al., 2007). Skeletal
muscle satellite cells are quiescent cells located adjacent to
muscle fibers and beneath the fiber basal lamina, which can be
induced to divide during conditions of muscle damage or
increased activation. Subsequent fusion with an existing
myofiber results in the addition of a myonucleus to the fiber
syncytium. The proposed role of the satellite cells in muscle
hypertrophy revolves around the concept of a myonuclear
domain—a theoretical volume of cytoplasm associated with a
single myonucleus—and each myofiber being composed of
many myonuclear domains (Allen et al., 1999). Satellite cells
provide a source for new myonuclei at a rate sufficient to main-
tain a constant myonuclear domain size during normal skeletal
muscle growth, thereby increasing the total number of myonu-
clei, and thus the total amount of genetic machinery available
for protein production with little alteration in the kinetics of
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experimental models including satellite cell depletion (McCarthy
et al., 2011) and myostatin inhibition (Wang and McPherron,
2012), skeletal muscle fiber hypertrophy is observed without
obligatory satellite cell incorporation. For instance, in skeletal
muscle with 90% of the satellite cell population depleted, over-
load-induced muscle hypertrophy is normal, whereas regenera-
tion from acutemuscle injury is impaired, suggesting that the role
of satellite cells is markedly different between the two muscle
growth paradigms (McCarthy et al., 2011). However, rodent
models of adaptive hypertrophy produce supraphysiological
gains in muscle size in a short time frame, e.g., functional over-
load induced by synergist ablation, and may not adequately
represent human adaptation (Booth and Thomason, 1991). In
human skeletal muscle, large ranges of interindividual variability
in themagnitude of hypertrophic response to resistance exercise
training are explained by the relative ability to mobilize satellite
cells and add myonuclei to existing muscle fibers (Petrella
et al., 2006; Petrella et al., 2008).
New Vistas in Molecular Exercise Physiology
Skeletal Muscle as a Secretory Organ
Over half a century ago, a humoral factor associated with exer-
cise but whose source was unknown was speculated to act in
an endocrine manner to regulate glycemia independent of insulin
(Goldstein, 1961). Although it is unlikely that only a single factor
regulated this effect, accumulating evidence today suggests
that skeletal muscle itself acts as a secretory organ during exer-
cise, such that cytokines and other metabolically active peptides
are produced and released into circulation (collectively known as
‘‘myokines’’). In turn, these proteins exert wider metabolic
effects on organs including fat, liver, gut, and pancreas and act
locally on muscle in an autocrine/paracrine manner (Pedersen
and Febbraio, 2012). For instance, IL-6 is a cytokine that can
regulate glycemia directly by stimulating glucose uptake in
skeletal muscle (Glund et al., 2007), and indirectly by acting on
L cells in the intestine and a cells in the pancreas to improve
b cell function and insulin secretion (Ellingsgaard et al., 2011).
Additionally, the exercise-induced effect on postexercise insulin
sensitivity is ablated in IL-6-deficient mice (Ellingsgaard et al.,
2011). IL-6 is one of many muscle-associated cytokines that
elicit a variety of effects potentially involved in exercise adapta-
tion, including hypertrophy and angiogenesis (Pedersen and
Febbraio, 2012). However, even at rest, the metabolic status of
skeletal muscle impacts whole-body metabolic homeostasis.
In vitro studies reveal that glucose-stimulated insulin release
from b cells is impaired when exposed to secretions from
insulin-resistant muscle cells, but not by secretions from
insulin-sensitive cells (Bouzakri et al., 2011). Recently, a novel
myokine irisin was discovered to activate the ‘‘browning’’ of
white fat, increase energy expenditure, and attenuate diet-
induced insulin resistance (Bostro¨m et al., 2012). While the
initial discovery was in response to supraphysiological PGC-1a
expression in skeletal muscle rather than contraction per se,
subsequent experiments demonstrated that circulating irisin
is modestly elevated in human and rodent training studies,
whereas blocking irisin action impairs the adaptive effects of
exercise on white adipose tissue remodeling (Bostro¨m et al.,
2012). Clearly, skeletal muscle as a secretory organ representsa fertile avenue for future research in translational medicine
and exploration of interorgan crosstalk in response to exercise,
but the extent of this regulation is unknown at present. Using
a computational approach to examine all genes expressed in
human skeletal muscle, >300 putative secretory proteins have
been detected based on the presence of signal peptides for
endoplasmic reticulum targeting and transmembrane segments
in protein sequences (Bortoluzzi et al., 2006). Almost one-quarter
of these proteins remain uncharacterized. Moreover, since
transcripts from resting muscle were used to generate these
cDNA libraries, other lowly expressed but exercise-responsive
transcripts (e.g., IL-6) may have been missed as false negatives.
Thus, given the abundance of potential secretory proteins, new
targets are likely on the horizon.
Posttranscriptional Regulation of Skeletal Muscle
Gene Expression
An emerging paradigm of molecular regulation involves the
action of microRNAs (miRNA). This class of short (18–24 nt),
noncoding RNA sequences regulate gene expression posttran-
scriptionally by inhibiting protein translation or augmenting
mRNA degradation through the canonical RNA interference
pathway (Ambros, 2004). miRNAs typically bind to complimen-
tary sequences within the 30UTR of a target gene to initiate this
process, but individual miRNAs have multiple gene targets,
and each gene target may be regulated by multiple miRNAs,
thereby intensifying the complexity of regulation. miRNAs have
been implicated in a range of metabolic processes and develop-
ment. For instance, miR-499, a muscle-enriched miRNA en-
coded within an intron of the MHC-I gene (Myh7b), is part of
a miRNA network proposed to regulate muscle fiber type via
downregulation of Sox6, Purb, and Sp3, repressors of MHC-I
expression (van Rooij et al., 2009). In mice overexpressing
miR-499, a conversion of type II fibers to predominantly type I
fibers is observed, which coincides with enhanced oxidative
metabolism and improved treadmill running capacity (van Rooij
et al., 2009). Furthermore, miRNA expression in skeletal muscle
is altered in response to atrophy (McCarthy et al., 2009), over-
load-induced hypertrophy (McCarthy and Esser, 2007), a single
bout of exercise (Nielsen et al., 2010), and exercise training
(Davidsen et al., 2011; Keller et al., 2011). The implications for
regulation of adaptive changes in skeletal muscle gene expres-
sion and function are unclear and require additional mechanistic
studies. Large-scale bioinformatics, based on prediction algo-
rithms and reciprocal relationships between miRNAs and their
target mRNAs, may prove fruitful for deriving nonobvious
hypotheses to investigate the molecular regulation of skeletal
muscle adaptation (Davidsen et al., 2011; Keller et al., 2011).
Heterogeneity in the Training Response: Personalized
Exercise Medicine
Even when participants engage in carefully controlled exercise
training regimens, the nature of the training response is remark-
ably heterogeneous, allowing the classification of non-, low, and
high responders (Bouchard et al., 1999; Hubal et al., 2005), and
even adverse responders (Bouchard et al., 2012). This interindi-
vidual variability includes a strong genetic component with,
for instance, a maximal heritability estimate of 50% for the
response of VO2max when adjusted for age, sex, baseline
VO2max, and body composition (Bouchard et al., 1999). Candi-
date gene studies have demonstrated only modest predictiveCell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc. 177
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ased, combined transcriptomic and genomic approaches to
examine the relationship between molecular responses and
physiological outcomes in response to exercise training have
yielded promising results for both aerobic (Timmons et al.,
2010) and resistance (Raue et al., 2012) training interventions.
For example, using this approach, a ‘‘predictor’’ gene set of 29
transcripts and 11 single nucleotide polymorphisms (SNPs)
explained 50% of the aforementioned genetic contribution to
the gain in VO2max in response to training (Timmons et al.,
2010). The key point is that these transcripts were not responsive
to training, but rather higher basal expression levels were pre-
dictive of greater gains in VO2max. Therefore, an attractive
hypothesis is that the exercise response (e.g., aerobic fitness,
strength, insulin sensitivity) can be predicted and understood
through combined molecular and physiological classifications
as a function of the individual and the exercise model (Timmons
et al., 2010; Raue et al., 2012). In essence, this would represent
the advent of personalized exercise medicine in which the exer-
cise prescription is matched to the individual and the condition
or desired outcome, as opposed to the currently broad public
health guidelines.
Similarly, a personalized exercise prescription could be used
to address factors such as a lack of time and lack of motivation,
which are among the most frequently cited barriers to exercise
participation (Booth et al., 1997). A lack of time may be
addressed by prescribing low-volume, short-duration, high-
intensity interval training. Even when total training time and
energy expenditure have been reduced by 80% and 90%,
respectively, improvements of VO2max, muscle oxidative
capacity, and insulin sensitivity are comparable to traditional
aerobic training (Burgomaster et al., 2008; Babraj et al., 2009).
A lack of motivation to exercise represents a more complex
phenomenon. Emerging evidence from mice selectively bred
for low versus high voluntary physical activity shows that
peripheral differences in metabolism and physiological function
are minimal between groups, and the majority of this biological
variation is explained by central factors, most likely at the level
of the dopaminergic system (reviewed in Knab and Lightfoot,
2010; Garland et al., 2011). Dissecting the molecular pathways
that regulate the motivation and perceived reward from exercise
may present a major avenue of future research, which may in
turn present new therapeutic targets to enhance exercise
participation.
Exercise Mimetics: Fact or Fallacy?
The observation of aerobic training-like phenotypes in trans-
genic mice (Wang et al., 2004; Calvo et al., 2008; Garcia-Roves
et al., 2008), or similar effects produced pharmacologically
(Lagouge et al., 2006; Narkar et al., 2008), has ignited interest
in developing so-called exercise ‘‘mimetics,’’ i.e., pharmaco-
therapy to replicate the metabolic effects of exercise. The
‘‘exercise in a pill’’ approach has been evaluated in detail
elsewhere (Booth and Laye, 2009; Carey and Kingwell, 2009)
and highlights that the complexities of the molecular response
and systemic multiorgan effects of exercise are beyond the
faculty of currently available monotherapeutic approaches.
With regard to ‘‘mimicking’’ exercise, a single pill is unlikely to
produce the myriad of acute physiological and metabolic
responses and consequent benefits. Thus, the term exercise178 Cell Metabolism 17, February 5, 2013 ª2013 Elsevier Inc.mimetic is a misnomer (Booth and Laye, 2009). Muscle contrac-
tion per se, an elevation in energy expenditure, and the turnover
of substrates are key features of exercise-mediated effects on
metabolic health and the initiation of signal transduction
cascades regulating adaptation. A true exercise mimetic would
therefore be akin to neuromuscular electrical stimulation, which
can bring about adaptive changes through involuntary exercise
(Banerjee et al., 2005). Due to the episodic nature of exercise,
metabolic homeostasis is maintained through cycling of meta-
bolic proteins in response to this intermittent stimulus.Moreover,
transgenic models with supraphysiological expression levels of
single proteins, e.g., PGC-1a, may well demonstrate an endur-
ance-like phenotype in skeletal muscle (Calvo et al., 2008) but
conversely exhibit insulin resistance and impaired glucose toler-
ance on a whole-body level (Choi et al., 2008). Nevertheless, the
value of pharmacotherapy in exercise-related interventions
should not be fully discounted. Pharmacological compounds
could serve as adjunct treatment to exercise to potentiate or
augment the adaptive response in exercisers. For instance,
pharmacotherapy could help overcome adaptive limitations in
insulin-resistant individuals with ‘‘exercise-resistant’’ skeletal
muscle (De Filippis et al., 2008), or in elderly individuals reported
to demonstrate ‘‘anabolic resistance’’ with respect to exercise-
induced MPS (Kumar et al., 2009).
Concluding Remarks
The metabolic and therapeutic effects of regular exercise on
lifestyle-related chronic disease are long established, but the
molecular bases for adaptive changes in skeletal muscle mass
and metabolic function remain an area of intense research. The
pleiotropic effects of exercise and the complexity of responses
at both a metabolic and a molecular level suggest that there is
no singular pathway mediating exercise training adaptation.
Mechanistic investigations have established many key players
in regulation of a healthy skeletal muscle phenotype, but the
viablility of these pathways as pharmaceutical entry points
remains to be determined. Alternatively, future therapeutic
potential may exist in optimizing targeted exercise interventions
and training prescription. From a translational perspective, this
would mean establishing the molecular signatures of targeted
exercise interventions based on factors such as mode, intensity,
or duration to optimize aerobic or strength adaptations, despite
presence of specific metabolic or muscular dysfunction. In this
sense, personalized, targeted exercise interventions may one
day complement the existing broad recommendations for exer-
cise in public health policy to address molecular defects present
in lifestyle-related chronic disease. This marriage between
complementary fields of research represents a new vista in exer-
cise science and illustrates the translational merit in utilizing
molecular approaches to explore the mechanistic bases of
training adaptation so as to inform exercise prescription.
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